Clinical Trial Update: A One-Arm Exploratory Clinical Trial of Apatinib Plus Gemcitabine in Patients With Advanced Metastatic Pancreatic Cancer [Phase 2]

View source ↗

Summary

A one-arm, Phase 2 exploratory trial evaluating apatinib in combination with gemcitabine for advanced/metastatic pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Apatinib (apatinib)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Metastatic Pancreatic Cancer | Phase 2 | Status: UNKNOWN